2016
DOI: 10.1111/vop.12353
|View full text |Cite
|
Sign up to set email alerts
|

Use of a nictitating membrane flap for treatment of feline acute corneal hydrops—21 eyes

Abstract: A nictitating membrane flap successfully treated 90.5% of FACH eyes (89.5% of patients).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
39
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 11 publications
(42 citation statements)
references
References 18 publications
(46 reference statements)
3
39
0
Order By: Relevance
“…A bridge graft was elected over a pedicle graft to theoretically aid in the desired effect of corneal tamponade through anticipated conjunctival contracture as the graft healed. Additional corneal tamponade was achieved through the placement a nictitating membrane flap, which has recently been reported as an effective treatment option for FACH . Although follow‐up in this case was limited, the combined surgical approach in this case appeared to have prevented further complication from FACH (such as corneal perforation), restored comfort, and preserved vision.…”
Section: Discussionsupporting
confidence: 81%
See 4 more Smart Citations
“…A bridge graft was elected over a pedicle graft to theoretically aid in the desired effect of corneal tamponade through anticipated conjunctival contracture as the graft healed. Additional corneal tamponade was achieved through the placement a nictitating membrane flap, which has recently been reported as an effective treatment option for FACH . Although follow‐up in this case was limited, the combined surgical approach in this case appeared to have prevented further complication from FACH (such as corneal perforation), restored comfort, and preserved vision.…”
Section: Discussionsupporting
confidence: 81%
“…Surgical repair was elected and consisted of a conjunctival bridge graft (Fig. a), nictitating membrane flap, and temporary tarsorrhaphy, performed under general anesthesia. The patient was discharged and prescribed ofloxacin 0.3% (1 drop q 4 h), amoxicillin trihydrate/clavulanate potassium 62.5 mg/ml powder for suspension (Clavamox Drops; Zoetis, Kalamazoo, MI, USA) (13.75 mg/kg q 12 h), atropine sulfate 1% (1 drop q 24 h), and buprenorphine hydrochloride 0.3 mg/ml solution (Buprenex; Reckitt Benckiser Pharmaceuticals Inc., Richmond, USA) (0.01 mg/kg q 8‐12 h PRN for pain).…”
Section: Case Summarysupporting
confidence: 84%
See 3 more Smart Citations